Literature DB >> 24023288

High lung-metastatic variant of human osteosarcoma cells, selected by passage of lung metastasis in nude mice, is associated with increased expression of α(v)β(3) integrin.

Yasunori Tome1, Hiroaki Kimura, Hiroki Maehara, Naotoshi Sugimoto, Michael Bouvet, Hiroyuki Tsuchiya, Fuminori Kanaya, Robert M Hoffman.   

Abstract

Altered expression of αvβ3 integrin is associated with tumor progression and metastasis in several types of cancer, including metastatic osteosarcoma. In this study, we demonstrate that in vivo passaging of lung metastasis in nude mice can generate an aggressive variant of human osteosarcoma cells. Experimental metastases were established by injecting 143B human osteosarcoma cells, expressing green fluorescent protein (GFP) in the nucleus and red fluorescent protein (RFP) in the cytoplasm, in the tail vein of nude mice. Lung metastases were harvested under fluorescence microscopy from nude mice to establish cell lines which were then injected via the tail vein of additional nude mice. This procedure was repeated for four passages in order to isolate highly metastatic variant sublines. When the parental and metastatic variants were transplanted orthotopically into the tibia of nude mice, the 143B-LM4 variant had the highest metastatic rate, approximately 18-fold higher than the parent (p<0.01). αvβ3 integrin expression was increased approximately 5.6-fold in 143B-LM4 compared to parental cells (p<0.05). Thus, serial passage of lung metastases created a highly metastatic variant of human osteosarcoma cells which had increased expression of αvβ3 integrin, suggesting that αvβ3 integrin plays an essential role in osteosarcoma metastasis. With this highly metastatic variant overexpressing αvβ3 integrin, it will now be possible to further investigate the mechanism by which αvβ3 integrin facilitates metastasis.

Entities:  

Keywords:  green fluorescent protein; lung metastasis; nude mice; osteosarcoma; overexpression; passage; red fluorescent protein; variants; αvβ3 integrin

Mesh:

Substances:

Year:  2013        PMID: 24023288

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Osteosarcoma cells enhance angiogenesis visualized by color-coded imaging in the in vivo Gelfoam® assay.

Authors:  Fuminari Uehara; Yasunori Tome; Shinji Miwa; Yukihiko Hiroshima; Shuya Yano; Mako Yamamoto; Sumiyuki Mii; Hiroki Maehara; Michael Bouvet; Fuminori Kanaya; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

Review 3.  Integrin αvβ3 Signaling in Tumor-Induced Bone Disease.

Authors:  Kristin A Kwakwa; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2017-07-08       Impact factor: 6.639

4.  Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.

Authors:  Tomohiro Fujiwara; Koji Uotani; Aki Yoshida; Takuya Morita; Yutaka Nezu; Eisuke Kobayashi; Akihiko Yoshida; Takenori Uehara; Toshinori Omori; Kazuhisa Sugiu; Tadashi Komatsubara; Ken Takeda; Toshiyuki Kunisada; Machiko Kawamura; Akira Kawai; Takahiro Ochiya; Toshifumi Ozaki
Journal:  Oncotarget       Date:  2017-05-16

5.  Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.

Authors:  Shingo Shimozaki; Norio Yamamoto; Takahiro Domoto; Hideji Nishida; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Kentaro Igarashi; Takashi Kato; Yu Aoki; Takashi Higuchi; Mayumi Hirose; Robert M Hoffman; Toshinari Minamoto; Hiroyuki Tsuchiya
Journal:  Oncotarget       Date:  2016-11-22

6.  The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.

Authors:  Yasunori Tome; Hiroaki Kimura; Naotoshi Sugimoto; Hiroyuki Tsuchiya; Fuminori Kanaya; Michael Bouvet; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-12-27

7.  βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin α2β1 and activating PI3K signaling pathway.

Authors:  Yun-Shan Guo; Rui Zhao; Jie Ma; Wei Cui; Zhen Sun; Bo Gao; Shu He; Yue-Hu Han; Jing Fan; Liu Yang; Juan Tang; Zhuo-Jing Luo
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

8.  Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer.

Authors:  Elizabeth Salvo; Saray Garasa; Javier Dotor; Xabier Morales; Rafael Peláez; Peter Altevogt; Ana Rouzaut
Journal:  Mol Cancer       Date:  2014-05-19       Impact factor: 27.401

9.  Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.

Authors:  Yasunori Tome; Hiroaki Kimura; Tasuku Kiyuna; Naotoshi Sugimoto; Hiroyuki Tsuchiya; Fuminori Kanaya; Michael Bouvet; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-07-19

10.  β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.

Authors:  Rafael Peláez; Xabier Morales; Elizabeth Salvo; Saray Garasa; Carlos Ortiz de Solórzano; Alfredo Martínez; Ignacio M Larrayoz; Ana Rouzaut
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.